auto_awesome
Want to know who else bid on this?
ProposalForge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
AbCellera Biologics Inc.Amount
$175.6M
Program
SIF Stream2- GrowthProvince
BCType
Other
Agreement Number
033-2020-2021-Q1-512889
Purpose
The project is in direct response to Canada's fight against COVID-19 and Canada's ability to respond to future pandemics. It will enable the rapid discovery of antibody therapies to treat and prevent COVID-19 and establish a Good Manufacturing Practice antibody production facility for Canada's long-term emergency preparedness.
AbCellera Biologics Inc. × Innovation, Science and Economic Development Canada
3 grants totalling $576.3M
SIF Stream2- Growth
63 grants totalling $4.5B
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| ArcelorMittal Dofasco G.P. | $450.0M | SIF Stream2- Growth |
| ArcelorMittal Dofasco G.P. | $450.0M | SIF Stream2- Growth |
| ArcelorMittal Dofasco G.P. | $400.0M | SIF Stream2- Growth |
| Air Products Canada LTD | $300.0M | SIF Stream2- Growth |
| Cohere Inc. | $240.0M | SIF Stream2- Growth |